| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Tyrosine-protein kinase Blk |
|---|
| Ligand | BDBM50054654 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_1699475 (CHEMBL4050457) |
|---|
| IC50 | 8.1±n/a nM |
|---|
| Citation |  Wang, A; Li, X; Wu, H; Zou, F; Yan, XE; Chen, C; Hu, C; Yu, K; Wang, W; Zhao, P; Wu, J; Qi, Z; Wang, W; Wang, B; Wang, L; Ren, T; Zhang, S; Yun, CH; Liu, J; Liu, Q Discovery of (R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (CHMFL-EGFR-202) as a Novel Irreversible EGFR Mutant Kinase Inhibitor with a Distinct Binding Mode. J Med Chem60:2944-2962 (2017) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Tyrosine-protein kinase Blk |
|---|
| Name: | Tyrosine-protein kinase Blk |
|---|
| Synonyms: | B lymphoid tyrosine kinase | BLK | BLK_HUMAN | SRC | Tyrosine-protein kinase BLK (BLK) | p55-Blk |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 57711.88 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P51451 |
|---|
| Residue: | 505 |
|---|
| Sequence: | MGLVSSKKPDKEKPIKEKDKGQWSPLKVSAQDKDAPPLPPLVVFNHLTPPPPDEHLDEDK
HFVVALYDYTAMNDRDLQMLKGEKLQVLKGTGDWWLARSLVTGREGYVPSNFVARVESLE
MERWFFRSQGRKEAERQLLAPINKAGSFLIRESETNKGAFSLSVKDVTTQGELIKHYKIR
CLDEGGYYISPRITFPSLQALVQHYSKKGDGLCQRLTLPCVRPAPQNPWAQDEWEIPRQS
LRLVRKLGSGQFGEVWMGYYKNNMKVAIKTLKEGTMSPEAFLGEANVMKALQHERLVRLY
AVVTKEPIYIVTEYMARGCLLDFLKTDEGSRLSLPRLIDMSAQIAEGMAYIERMNSIHRD
LRAANILVSEALCCKIADFGLARIIDSEYTAQEGAKFPIKWTAPEAIHFGVFTIKADVWS
FGVLLMEVVTYGRVPYPGMSNPEVIRNLERGYRMPRPDTCPPELYRGVIAECWRSRPEER
PTFEFLQSVLEDFYTATERQYELQP
|
|
|
|---|
| BDBM50054654 |
|---|
| n/a |
|---|
| Name | BDBM50054654 |
|---|
| Synonyms: | CHEMBL4068839 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C25H24ClN7O2 |
|---|
| Mol. Mass. | 489.957 |
|---|
| SMILES | Nc1ncnc2n(nc(-c3ccc(OCc4ccccn4)c(Cl)c3)c12)[C@@H]1CCCN(C1)C(=O)C=C |r| |
|---|
| Structure | 
|
|---|
Search and Browse
